|
[Symposium 04] Interstitial Lung Disease 1 - Wide Spectrum of Fibrotic Lung Diseases in Real World |
15:10-16:30 |
||
|---|---|---|---|
| Chair | |||
| 10:30-11:00 | SY 4-1 |
Wide Spectrum of Fibrotic Lung Disease in Real World
|
|
| 11:00-11:30 | SY 4-2 |
Diagnosis and Management of Interstitial Lung Disease in Rheumatoid Arthritis
|
|
| 11:30-12:00 | SY 4-3 |
SSc-ILD: Current Evidences and Application
|
|
|
[Luncheon Symposium 02] Interstitial Lung Disease
|
11:00-12:00 |
||
| Chair | |||
| 12:00-12:30 | LS 2 |
Antifibrotic Therapy in Japan: Long Term Treatment Experience of Pirfenidone
|
|
|
[Symposium 05] Interstitial Lung Disease 2 - Update of Rare and Orphan Lung Diseases |
15:10-16:00 |
||
| Chair | |||
| 13:30-14:00 | SY 5-1 |
Pulmonary Alveolar Proteinosis: No Longer Orphan in New Era?
|
|
| 14:00-14:30 | SY 5-2 |
Lymphangioleiomatosis
|
|
| 14:30-15:00 | SY 5-3 |
Pleuroparenchymal Fibroelastosis (PPFE)
|
|
|
[Satellite Symposium 3] Interstitial Lung Disease / Airway Disease
|
09:00-10:30 |
||
| Chair | |||
| 17:15-17:45 | SS 3-1 |
Exploring Optimal Treatment Options for Progressive Fibrosing ILDs : How to Treat?
|
|
| 17:45-18:15 | SS 3-2 |
What Do COPD Real World Studies Tell Us about LAMA/LABA Initiation in Maintenance Therapy?
|
|